Publication | Closed Access

Tumour necrosis factor-alpha, interleukin-6, and fasting serum insulin correlate with clinical outcome in metastatic breast cancer patients treated with chemotherapy

Metabolic SyndromeSerum Insulin CorrelateBreast OncologyMedicineImmunologyPathologyBreast CancerCancer TreatmentClinical OutcomeOncologyTumor MicroenvironmentEndocrine-related Cancer